Form 4 for ERAS Erasca, Inc.
Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-14 · accession 0001209191-22-061352 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-12-15 | 2022-12-14 | ERAS | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $4.99 | +40.0K | 20.20M | +0.2% | +$199.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-14 | P | A | 40,000 | $4.99 | 20,196,222 | I By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005 | — | — | (F1) The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005. |